Vycor Medical (VYCO) FCF Margin (2010 - 2026)

Vycor Medical (VYCO) has 17 years of FCF Margin data on file, last reported at 21.68% in Q1 2026.

• FCF Margin for Q1 2026 came in at 21.68%, up 2785.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.9% (up 405.0% YoY), and the FY2025 annual result was 1.0%, down 445.0% from the prior year.
• FCF Margin advanced to 21.68% in Q1 2026 per VYCO's latest filing, from 9.03% in the prior quarter.
• Over five years, FCF Margin peaked at 21.68% in Q1 2026 and troughed at 25.1% in Q1 2022.
• A 5-year average of 1.76% and a median of 0.13% in 2023 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2023: FCF Margin sank 2449 bps in 2022, then surged 3192 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 12.18% in 2022, then surged by 99 bps to 0.13% in 2023, then sank by 6445 bps to 8.41% in 2024, then soared by 207 bps to 9.03% in 2025, then surged by 140 bps to 21.68% in 2026.
• Business Quant data shows VYCO's FCF Margin at 21.68% in Q1 2026, 9.03% in Q4 2025, and 14.1% in Q3 2025.